InvestorsHub Logo
Followers 13
Posts 438
Boards Moderated 0
Alias Born 01/06/2015

Re: WHS post# 16261

Wednesday, 12/02/2015 7:22:22 AM

Wednesday, December 02, 2015 7:22:22 AM

Post# of 32016
Why SNY won't terminate Afrezza 2016....

Afrezza is the future.
Plus MNKD has 4 other types of medicine for inhalers in the works.
SNY would lose that too.

SNY is afraid somesome else can come in take over all licensing
and then they have to compete with Afrezza after
it becomes more popular than injections.

MNKD may choose to license it to several companies
under their own trademark brand names.

There are lots of ways this can go and if SNY loses
AFrezza control they may never get another chance.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y